Markets

Exchanges

Wall Street’s best frenemy

Ken Griffin
Getty Images

Wall Street underestimates Ken Griffin at its peril

6/6/24 9:42AM

News that Ken Griffin’s trading behemoth Citadel Securities — along with asset management giant BlackRock — are part of a group backing a new national stock exchange based in Dallas was largely shrugged off on Wednesday.

After all, other recent efforts to uproot lower Manhattan from its century-long position as the key chokepoint of global capitalism haven’t moved the needle much. Remember IEX? The Long-Term Stock Exchange? Both failed to make much of a dent in the dominant position of the New York Stock Exchange, Nasdaq, and CBOE.

And the $120 million in funding the new exchange, TXSE, was touting is — let’s face it — peanuts when it comes to the expense of building and maintaining the type of trading technology that would be needed to establish a reliable electronic exchange.

But this is missing something important: It’s called Ken Griffin.

The billionaire financier — a hedge-fund manager and market-making and trading technology entrepreneur — poses a unique competitive problem that Wall Street has repeatedly failed to solve in recent years, as his ever-expanding trading empire has been able to lop off larger chunks of business Wall Street once owned. (This is a big part of the reason Griffin is personally now worth more than $40 billion.)

(Disclosure: Sherwood News is an editorially independent subsidiary of Robinhood Markets, Inc. Citadel Securities has a business relationship with Robinhood.)

Making a market

Since Griffin established his market-making unit, Citadel Securities, in 2002, it has grown into a significant — and in some instances, dominant — player in businesses long controlled by Wall Street institutions.

Most of these businesses involve Wall Street’s core competency: matching buyers and sellers for a range of investments, including options, foreign exchange, and corporate and government bonds. Citadel Securities has also kicked in the door of the incredibly profitable interest rate swaps trading business that was long a cherished, and closely guarded, profit center for major Wall Street banks like J.P. Morgan, Goldman Sachs and Bank of America.

How has Griffin and his hand-picked executives been able to do it? Well, over the years, I’ve spoken privately with Wall Street traders and executives who say it has to do with the unique positioning Griffin’s empire has as Wall Street’s best frenemy.

Here’s what they say: While his trading division — he is the founder and largest shareholder in Citadel Securities, though no longer runs it day-to-day — is perhaps Wall Street’s biggest competitor, he is also the CEO of a $60 billion-plus hedge fund known as Citadel Advisors — legally distinct from the Citadel Securities trading arm — which is one of Wall Street’s biggest clients.

Essentially, Wall Street is terminally conflicted about how to respond to Griffin’s competitive incursions.

Executives are reluctant to declare an all-out competitive war with Griffin, for fear of A) losing and B) jeopardizing the lucrative trading commissions and prime brokerage business that his hedge fund throws their way. There’s also a C) wild card, in that in their heart of hearts, many of Wall Street’s elite executives could envision themselves occupying a well-compensated chair at Citadel some day.

Wall Street’s best frenemy

By the way, Citadel Securities could be said to have a similar frenemy position toward stock exchanges. While the company’s principal trading business — which uses its own capital to execute trades off exchanges — is a major competitor with exchanges, Citadel is also a major business partner of the NYSE and has been for a long time.  

Today, Citadel remains the NYSE’s top designated market maker. It has responsibility for managing trading in some 2,000 stocks, or about 65% of listings. That effectively makes Citadel Securities one of the one of the biggest business partners of the venerable stock exchange, which is owned by IntercontinentalExchange.

Political power

The Griffin-related risks don’t stop there for stock exchanges.

While the heavily regulated nature of public stock trading has long served as something of a competitive moat for exchanges, Griffin’s political muscle could help cut through the protective cocoon and red tape of exchanges.

Bottom line? Citadel Securities is already one of the most important nodes of the stock trading business, executing — that is, matching buyers and sellers — 23% of all publicly reported US trades last year.

It’s unclear how serious Citadel Securities is about putting financial or trading firepower behind any upstart stock exchange. (It has backed other exchanges in the past, perhaps most notably the Members Exchange or MEMX, in 2019.)

But by definition, any exchange, even an as-yet nonexistent one like the TXSE, seriously backed by Citadel Securities could be a threat. Wall Street, consider yourself warned.

More Markets

See all Markets
markets

CoreWeave soars on $6.3 billion cloud computing purchasing agreement with Nvidia

Shares of CoreWeave are flying higher in early trading after the company struck an agreement with Nvidia that will see the chip designer purchase all of CoreWeave’s unused cloud computing capacity through April 13, 2032.

The new order has an initial value of $6.3 billion, per a filing from CoreWeave that outlines this modification to its April 2023 services deal with Nvidia.

Securing access to cloud computing capacity has been the hot topic in the AI space, which was underscored by last week’s deal between Microsoft and Nebius as well as Oracle’s mammoth pipeline of sales, thanks in large part to OpenAI.

As such, it strikes me as a bit odd that this particular agreement for CoreWeave — securing full utilization of its cloud computing capacity, which everyone seems to want and where demand appears to outstrip supply — is such a big deal, but hey.

Nvidia has secured a high degree of vertical integration throughout the AI ecosystem through its equity positions and partnerships with cloud computing and data center companies.

markets

Novo Nordisk’s GLP-1 pill gets EU approval for cardiovascular benefits

Novo Nordisk rose in early trading after it announced that European regulators approved its diabetes pill to be marketed for cardiovascular benefits as well.

Rybelsus — a pill version of semaglutide, the active ingredient in Ozempic and Wegovy — will now list cardiovascular benefits on its label in the European Union. In the US, the Food and Drug Administration is expected to decide on adding the cardiovascular indication for Rybelsus later this year.

Wegovy, Novo’s blockbuster weight-loss shot, is approved to treat cardiovascular conditions in the US and EU. Expanding the conditions Novo’s drugs can be prescribed for could help the Danish pharmaceutical giant spark growth as it faces pressure from Eli Lilly’s competitor drugs.

markets

Investors pour into Joby and Archer after White House announces air taxi pilot program participation

On Friday, Transportation Secretary Sean Duffy announced the creation of a new FAA pilot program aimed at speeding up the development of “advanced air mobility” vehicles, including electric air taxis made by Joby Aviation and Archer Aviation.

Joby shares climbed more than 5% in premarket trading on Monday, after closing up 2% on Friday. Archer shares rose 7% in the premarket, following a 3% jump. Both companies announced their plans to participate in the eVTOL Integration Pilot Program (eIPP), which the FAA says will include at least five projects and run for three years.

Both companies have been burning cash as they work toward FAA certification to kick off their commercial air taxi businesses in the US. Joby last month said it’s 70% complete with the fourth stage of its five-stage certification process.

The eIPP was first hinted at in President Trump’s June executive order, aimed at speeding up adoption of the electric vertical takeoff aircraft.

markets

IonQ rises on wave of Wall Street love following its Analyst Day event

IONQ’s Analyst Day event at the New York Stock Exchange on Friday was a major catalyst for the quantum computing space.

Its stock spiked 18% on the final session of last week, leading a charge that saw peers Rigetti Computing up 14%, D-Wave Quantum gain 7.5%, and Quantum Computing rise 7%.

Analysts obviously liked what they heard. Shares are up again in early trading on Monday, with IonQ’s price target hiked:

  • to $80 from $60 by Needham,

  • to $75 from $61 by B Riley Securities, and

  • to $60 from $45 by Cantor Fitzgerald.

“IonQ is the only company in the industry to have quantum computing, quantum networking and quantum security under one roof,” wrote Needham analyst N. Quinn Bolton, who has a “buy” rating on the shares. “Management highlighted the US Department of War recently stated ‘Cryptographically relevant quantum computers may be possible in as soon as three years.’ This fact is driving growing interest in the company’s QKD [quantum key distribution] systems.”

The company also announced on Friday that it received regulatory approval for its purchase of British startup Oxford Ionics and expects the deal to close shortly.

“We believe Oxford Ionic’s Electronic Qubit Control is a highly differentiated technology that not only enables significantly greater scalability but also enables higher fidelity and faster gate speeds,” Bolton added.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.